1. Home
  2. ATRC vs DCO Comparison

ATRC vs DCO Comparison

Compare ATRC & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • DCO
  • Stock Information
  • Founded
  • ATRC 2000
  • DCO 1849
  • Country
  • ATRC United States
  • DCO United States
  • Employees
  • ATRC N/A
  • DCO N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • DCO Military/Government/Technical
  • Sector
  • ATRC Health Care
  • DCO Industrials
  • Exchange
  • ATRC Nasdaq
  • DCO Nasdaq
  • Market Cap
  • ATRC 1.1B
  • DCO 1.0B
  • IPO Year
  • ATRC 2005
  • DCO N/A
  • Fundamental
  • Price
  • ATRC $38.39
  • DCO $61.26
  • Analyst Decision
  • ATRC Strong Buy
  • DCO Strong Buy
  • Analyst Count
  • ATRC 10
  • DCO 4
  • Target Price
  • ATRC $49.50
  • DCO $73.50
  • AVG Volume (30 Days)
  • ATRC 539.4K
  • DCO 70.4K
  • Earning Date
  • ATRC 02-12-2025
  • DCO 02-27-2025
  • Dividend Yield
  • ATRC N/A
  • DCO N/A
  • EPS Growth
  • ATRC N/A
  • DCO 41.24
  • EPS
  • ATRC N/A
  • DCO 2.00
  • Revenue
  • ATRC $465,307,000.00
  • DCO $781,490,000.00
  • Revenue This Year
  • ATRC $14.41
  • DCO $4.72
  • Revenue Next Year
  • ATRC $12.87
  • DCO $5.51
  • P/E Ratio
  • ATRC N/A
  • DCO $31.29
  • Revenue Growth
  • ATRC 16.55
  • DCO 3.78
  • 52 Week Low
  • ATRC $18.94
  • DCO $47.53
  • 52 Week High
  • ATRC $43.11
  • DCO $70.50
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 47.41
  • DCO 29.54
  • Support Level
  • ATRC $37.72
  • DCO $61.95
  • Resistance Level
  • ATRC $42.68
  • DCO $63.27
  • Average True Range (ATR)
  • ATRC 1.78
  • DCO 1.73
  • MACD
  • ATRC -0.59
  • DCO -0.73
  • Stochastic Oscillator
  • ATRC 13.51
  • DCO 9.60

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: